Research Site

Edmonton T6G 2G3

1 studies enrolling now · 6 studies all time

What they study most

Advanced Clear Cell Renal Cell Carcinoma, Breast Cancer, Cerebral Stroke, Cerebrovascular Stroke, Ischemic Attack, Transient, Lymphoma, Mantle Cell, Metastatic Clear Cell Renal Cell Carcinoma, Relapsing-Remitting Multiple Sclerosis, Stroke, Acute

Studies at this site

• Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma — Recruiting now
• A Study of BR Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated MCL — Running, not enrolling
• BG00012 Monotherapy Safety and Efficacy Extension Study in Multiple Sclerosis (MS) — Completed
• Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis — Completed
• Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer — Completed
• Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke — Completed